Inter-rater reliability and validity of supervision performance assessment and recognition (SPARS) indicators to assess medicines management in public health facilities in Nepal

被引:0
作者
Adhikari, Santusta [1 ,2 ]
Bastola, Anup [3 ]
Shrestha, Reekesh [1 ,2 ]
Khanal, Narendra Kumar [3 ]
Trap, Birna [1 ,2 ]
机构
[1] USAID Med Technol & Pharmaceut Serv MTaPS, Kathmandu, Nepal
[2] Management Sci Hlth, Arlington, VA USA
[3] Minist Hlth & Populat, Dept Hlth Serv, Curat Serv Div, Kathmandu, Nepal
关键词
SPARS; inter-rater reliability; IRR; validity; indicators; medicines management indicators; medicines management supervisors; performance assessment quality; data quality audit; data quality;
D O I
10.1080/20523211.2025.2477098
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Nepal's Ministry of Health and Population piloted the Supervision, Performance Assessment, and Recognition Strategy (SPARS), a multipronged strategy to improve medicines management practices in health facilities. Medicines management supervisors (MMS) periodically assess facility performance using 25 indicators grouped into 5 domains - prescribing, dispensing, ordering and reporting quality and stock and storage management - and provide targeted on-the-job coaching. This study aimed to determine inter-rater reliability (IRR) and validity for SPARS indicators in Nepali context. Methods: We assessed IRR and validity scores with three rater teams assessing medicines management in six public health posts. Each team of three MMS and one technical advisor evaluated two facilities, resulting in 24 total assessments. We calculated the mean and median validity and IRR scores for SPARS overall, and by domain and indicator. Acceptable scores were mean validity and IRR scores >= 75%, moderately acceptable were 50-75%, and unacceptable were <50%. Results: The mean overall IRR (60%) and validity (74%) of all 25 SPARS indicators were significantly different (p < 0.003) but not by domain. Three domains related to dispensing, ordering and reporting, and storage had acceptable mean validity scores, while the prescribing quality domain had an unacceptable mean IRR score. We found significant difference (p < 0.0001) between the indicator IRR and validity acceptability scores. Four (16%) and 12 (48%) of the SPARS indicators had acceptable reproducibility and validity, respectively; 8 (33%) IRR scores and 1 (4%) validity score were unacceptable. Simple indicators (67%) had significantly (p < 0.02) higher reproducibility compared to complex indicators (42%), and higher validity of 80% and 72%, respectively, which was not significant. Conclusions: This study demonstrated that the SPARS indicators produce moderately accurate findings. Validity was significantly higher than IRR and both need improvement, especially for complex indicators. As such, future SPARS implementation should endeavour to include validity and IRR assessments to help improve the indicators.
引用
收藏
页数:26
相关论文
共 20 条
[1]  
Acharya A., 2020, J Pharm Pr Educ, V3, P25, DOI [10.36648/pharmacy-practice.3.2.25, DOI 10.36648/PHARMACY-PRACTICE.3.2.25]
[2]  
[Anonymous], 1993, How to investigate drug use in health facilities: selected drug use indicators
[3]  
[Anonymous], 2012, MDS-3: Managing access to medicines and health technologies
[4]   Supervision, performance assessment, and recognition strategy (SPARS) - a multipronged strategy to strengthen medicines management in Nepal: pilot study methods and baseline results [J].
Bhusal, Nirajan ;
Bastola, Anup ;
Shrestha, Reekesh ;
Khanal, Narendra Kumar ;
Trap, Birna .
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2025, 18 (01)
[5]   Evaluating inter-rater reliability of indicators to assess performance of medicines management in health facilities in Uganda [J].
Blick B. ;
Nakabugo S. ;
Garabedian L.F. ;
Seru M. ;
Trap B. .
Journal of Pharmaceutical Policy and Practice, 11 (1)
[6]  
Embrey M., 2018, Supervision, performance assessment, and recognition strategy to strengthen medicines management in Uganda: Case study
[7]   FIELD-TESTS FOR RATIONAL DRUG-USE IN 12 DEVELOPING-COUNTRIES [J].
HOGERZEIL, HV ;
BIMO ;
ROSSDEGNAN, D ;
LAING, RO ;
OFORIADJEI, D ;
SANTOSO, B ;
CHOWDHURY, AKA ;
DAS, AM ;
KAFLE, KK ;
MABADEJE, AFB ;
MASSELE, AY .
LANCET, 1993, 342 (8884) :1408-1410
[8]  
Karki B. K., 2017, Quality of drugs and drug use patterns at different levels of health care settings in Nepal
[9]   Ten recommendations to improve use of medicines in developing countries [J].
Laing, RO ;
Hogerzeil, HV ;
Ross-Degnan, D .
HEALTH POLICY AND PLANNING, 2001, 16 (01) :13-20
[10]   Interrater reliability: the kappa statistic [J].
McHugh, Mary L. .
BIOCHEMIA MEDICA, 2012, 22 (03) :276-282